Arcturus Therapeutics Holdings Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARCT Nasdaq 2836 arcturusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Q2 Earnings Call Highlights - Aug 6th, 2026 4:04 pm
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates - Aug 6th, 2026 3:20 pm
Exelixis (EXEL) Tops Q2 Earnings Estimates - Aug 5th, 2026 4:10 pm
PTC Therapeutics (PTCT) Beats Q2 Earnings and Revenue Estimates - Jul 30th, 2026 3:25 pm
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 - Jul 28th, 2026 2:01 pm
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference - Jul 20th, 2026 2:01 pm
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar? - Jul 3rd, 2026 5:06 am
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis - Jul 2nd, 2026 5:00 am
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies - Jun 5th, 2026 3:02 am
Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2026 3:55 pm
Arcturus Therapeutics Q1 Earnings Call Highlights - May 7th, 2026 3:39 pm
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates - Apr 30th, 2026 4:25 pm
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - Mar 25th, 2026 9:12 am
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf - Mar 23rd, 2026 12:47 pm
These Are the Only 3 Stocks That Cathie Wood Bought Last Week - Mar 23rd, 2026 5:27 am
Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing - Mar 12th, 2026 12:02 am
Arcturus Therapeutics Holdings Inc. Q4 2025 Earnings Call Summary - Mar 4th, 2026 6:02 pm
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call Highlights: Navigating Revenue ... - Mar 3rd, 2026 10:01 pm
Arcturus Therapeutics Q4 Earnings Call Highlights - Mar 3rd, 2026 4:02 pm